SET Polyclonal Antibody

The SET Polyclonal Antibody is applicable for the following applications: ELISA, WB. Host: Rabbit. Species Reactivity: Human (Homo sapiens) . Immunogen: Recombinant Human Protein SET protein (147-235AA) . Accession Number: Q01105. Target Synonyms: 2PP2A; HLA DR associated protein II; HLA-DR-associated protein II; I 2PP2A; I-2PP2A; I2PP2A; IGAAD; Inhibitor of granzyme A activated DNase; Inhibitor of granzyme A-activated DNase; Inhibitor of GzmA-activated DNase; inhibitor-2 of protein phosphatase-2A; IPP2A2; PHAPII; Phosphatase 2A inhibitor I2PP2A; protein phosphatase type 2A inhibitor; Protein SET; Set; SET nuclear oncogene; SET translocation; SET translocation (myeloid leukemia-associated) ; SET_HUMAN; TAF I; TAF IBETA; TAF-I; TAFI; Template activating factor I; Template-activating factor I; Template-Activating Factor-I; chromatin remodelling factor. Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Product Specifications

Short Description

The SET Polyclonal Antibody is applicable for the following applications: ELISA, WB.

Accession Number

Q01105

Host

Rabbit

Reactivity

Human (Homo sapiens)

Immunogen

Recombinant Human Protein SET protein (147-235AA)

Target

SET

Clonality

Polyclonal

Conjugation

Unconjugated. Conjugated antibodies are available (Biotin, FITC and HRP), please inquire.

Applications

ELISA, WB

Field of Research

Immunology

Purification

>95%, Protein G purified

Concentration

Lot specific. Please inquire or refer to the datasheet included in the product pouch.

Buffer

0.03% Proclin 300, 50% glycerol, 0.01M PBS, pH 7.4

Shipping Conditions

Ice packs

Storage Conditions

2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

Appearance

Liquid

Fragment

IgG

Target Alternative Name

2PP2A; HLA DR associated protein II; HLA-DR-associated protein II; I 2PP2A; I-2PP2A; I2PP2A; IGAAD; Inhibitor of granzyme A activated DNase; Inhibitor of granzyme A-activated DNase; Inhibitor of GzmA-activated DNase; inhibitor-2 of protein phosphatase-2A; IPP2A2; PHAPII; Phosphatase 2A inhibitor I2PP2A; protein phosphatase type 2A inhibitor; Protein SET; Set; SET nuclear oncogene; SET translocation; SET translocation (myeloid leukemia-associated) ; SET_HUMAN; TAF I; TAF IBETA; TAF-I; TAFI; Template activating factor I; Template-activating factor I; Template-Activating Factor-I; chromatin remodelling factor